Synthetic peptide TEKKRRETVEREKE derived from ezrin induces differentiation of NIH/3T3 fibroblasts

Marina Chulkina, Ulugbek Negmadjanov, Ekaterina Lebedeva, Aleksey Pichugin, Dmitriy Mazurov, Ravshan Ataullakhanov, Ekhson Holmuhamedov

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Synthetic 14 AA peptide (Gepon) derived from the hinge region of ezrin, a protein that links cell surface molecules to intracellular actin filaments, accelerates and facilitates wound and ulcer healing in clinical applications. However, the molecular mechanisms underlying this phenomenon and involved in enhanced healing of wounds with Gepon are not yet understood. The purpose of current study was to investigate intracellular signaling pathways involved in the effect of this peptide on wild type and genetically modified (CD44 KO) NIH/3T3 embryonic mouse fibroblasts. Gepon treatment of NIH/3T3 cells resulted in morphological and biochemical changes, characteristic of differentiated fibroblasts. While treatment of NIH/3T3 cells with TGF-β1 triggered the activation of both canonical and non-canonical signaling pathways, exposure of fibroblasts to Gepon activated only the ERK1/2 dependent pathway without modulating SMAD dependent signaling pathway. Knocking out hyaluronic acid CD44 receptor did not change Gepon or TGF-β1 dependent activation of intracellular signaling pathways and assembling of α-SMA-positive filaments. Gepon dependent differentiation of NIH/3T3 fibroblasts is based on activation of ERK1/2 kinase, non-canonical intracellular signaling pathway. Our data suggest that the treatment of fibroblasts with Gepon triggers activation of the non-canonical (SMAD independent) intracellular signaling pathway that involves ERK1/2kinase phosphorylation. Activation of the MAPK signaling pathway and the increase in formation of α-SMA containing stress filaments induced by Gepon were independent on presence of CD44 receptor in NIH/3T3 fibroblasts. Thus, our observation designates the significance and sufficiency of MAPK pathway mediated activation of fibroblasts with Gepon for healing of erosion, ulcers and wounds.

Original languageEnglish (US)
Pages (from-to)249-259
Number of pages11
JournalEuropean Journal of Pharmacology
Volume811
DOIs
StatePublished - 2017
Externally publishedYes

Bibliographical note

Funding Information:
This work has been supported by Immapharma (Moscow, Russia) and Russian Science Foundation (#15-15-00135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Publisher Copyright:
© 2017 Elsevier B.V.

Keywords

  • Fibroblasts
  • Gepon
  • MAPK/ERK1/2
  • SMAD2/3
  • TGF-β1
  • α-SMA

Fingerprint

Dive into the research topics of 'Synthetic peptide TEKKRRETVEREKE derived from ezrin induces differentiation of NIH/3T3 fibroblasts'. Together they form a unique fingerprint.

Cite this